Cerivastatin, a HMG-CoA reductase inhibitor, reduces plasminogen activator inhibitor-1 (PAI-1) expression in endothelial cells by down-regulation of cellular signaling and the inhibition of PAI-1 promoter activity - Swiatkowska, M; Pawlowska, Z; Szemraj, J (Jpn J Pharmacol, 2002)
et al.